The government of Kazakhstan has allocated over 9.7 billion tenge from reserves to purchase more than 351,000 doses of the HPV vaccine. Prime Minister Olzhas Bektenov signed the resolution, enabling the introduction of HPV vaccination nationwide through targeted transfers to regional and city budgets.
The government has allocated reserve funds to purchase the human papillomavirus (HPV) vaccine, enabling the introduction of HPV vaccination in Kazakhstan. The resolution was signed by Prime Minister Olzhas Bektenov.
More than 9.7 billion tenge will be transferred to the budgets of regions, cities of national significance, and the capital as targeted current transfers to acquire over 351,000 doses of the vaccine.
Cervical cancer (CC), caused by HPV, is one of the most common cancers worldwide, accounting for up to 13.1% of all cases. Approximately 300,000 women die from it annually. In Kazakhstan, cervical cancer ranks second in prevalence among cancers affecting women of all ages. Each year, around 1,900 new cases are reported nationwide, with over 600 women dying from this disease.
Vaccination is the only method to prevent HPV and the development of cervical cancer. According to Kazakhstan’s National Immunization Schedule and WHO recommendations, HPV vaccination will be administered to 11-year-old girls in two doses, with a six-month interval. The country will use a quadrivalent vaccine, which protects against the most oncogenic HPV types (6, 11, 16, and 18).
The full article here.
